Nasasbiotech is a biotechnology company that develops novel clinical solutions to improve the diagnosis, prognosis and treatment of cancer.
Our research is primarily focused on the study of circulating tumour cells or CTCs, their role in the formation of metastasis, their use as tools of diagnosis and prognosis, and the development of systems for their control and capture.
More about us
Who we are?
Nasasbiotech is a biotechnology company that develops novel clinical solutions to improve the diagnosis, prognosis and treatment of cancer.
Our research is primarily focused on the study of circulating tumour cells or CTCs, their role in the formation of metastasis, their use as tools of diagnosis and prognosis, and the development of systems for their control and capture.
More about us
Our developments
We analyze the mechanisms by which a tumoural cell is able to leave the primary tumour, and after understanding what it is looking for in another tissue to form metastasis; we change or modulate this process by offering a niche, a much more attractive artificial tissue, where all tumoural cells will preferentially nest.
We, therefore, are able to offer the oncologist the opportunity to take back control of the patient and to return the patient returns to a stage of a located primary tumour where the oncologist has highly effective tools as surgery or radiotherapy.
Know more
Latest news
-
NasasBiotech is born!
in NasasBiotechNasasbiotech has been promoted by the researchers of the Translational Medical Oncology La...
-
New publication of MTRAP technology released
in NasasBiotechThe Journal of the National Cancer Institute (JNCI)has published an article highlighting t...
Funders and partners
Science Seed Fund
PRIS program
